Imaging the epileptic brain with positron emission tomography.

Positron emission tomography (PET) has an established role in the noninvasive localization of epileptic foci during presurgical evaluation. [18F]fluorodeoxyglucose (FDG) PET is able to lateralize and regionalize potentially epileptogenic regions in patients who have normal MR imaging and is also useful in the evaluation of various childhood epilepsy syndromes, including cryptogenic infantile spasms and early Rasmussen's syndrome. Novel PET tracers that were developed to image neurotransmission related to gamma-aminobutyric acid (GABA) [with [11C]flumazenil] and serotonin-mediated [with alpha-[11C]methyl-L-tryptophan (AMT)] function provide increased specificity for epileptogenic cortex and are particularly useful when FDG PET shows large abnormalities of glucose metabolism. Detailed comparisons of PET abnormalities with intracranial electroencephalographic findings also improve our understanding of the pathophysiology of human epilepsy.

[1]  Conrad V. Kufta,et al.  Temporal lobectomy for uncontrolled seizures: The role of positron emission tomography , 1992, Annals of neurology.

[2]  M. Newton,et al.  Ictal SPECT and Interictal PET in the Localization of Occipital Lobe Epilepsy , 2000, Epilepsia.

[3]  V J Cunningham,et al.  Central benzodiazepine receptors in malformations of cortical development: A quantitative study. , 2001, Brain : a journal of neurology.

[4]  R Sankar,et al.  Surgery for Intractable Infantile Spasms: Neuroimaging Perspectives , 1993, Epilepsia.

[5]  S. Weinstein,et al.  Low incidence of abnormal 18FDG-PET in children with new-onset partial epilepsy: A prospective study , 2002, Neurology.

[6]  I Savic,et al.  Pattern of interictal hypometabolism in PET scans with fludeoxyglucose F 18 reflects prior seizure types in patients with mesial temporal lobe seizures. , 1997, Archives of neurology.

[7]  Alan A. Wilson,et al.  Mu‐opiate receptors measured by positron emission tomography are increased in temporal lobe epilepsy , 1988, Annals of neurology.

[8]  H G Wieser,et al.  Preoperative and postoperative glucose consumption in mesiobasal and lateral temporal lobe epilepsy , 1994, Neurology.

[9]  A. Wilson,et al.  L-methionine uptake by human cerebral cortex: maturation from infancy to old age. , 1991, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[10]  O. Muzik,et al.  Alpha-methyl-l-tryptophan PET detects epileptogenic cortex in children with intractable epilepsy , 2003, Neurology.

[11]  H G Wieser,et al.  Mesiobasal versus lateral temporal lobe epilepsy , 1993, Neurology.

[12]  M. Phelps,et al.  Infantile spasms: I. PET identifies focal cortical dysgenesis in cryptogenic cases for surgical treatment , 1990, Annals of neurology.

[13]  M E Phelps,et al.  Epileptic patterns of local cerebral metabolism and perfusion in humans determined by emission computed tomography of 18FDG and 13NH3 , 1980, Annals of neurology.

[14]  Otto Muzik,et al.  Identification of Frontal Lobe Epileptic Foci in Children Using Positron Emission Tomography , 1997, Epilepsia.

[15]  R. Worth,et al.  Comparative study of interictal PET and ictal SPECT in complex partial seizures , 1997, Acta neurologica Scandinavica.

[16]  O Muzik,et al.  Intracranial EEG versus flumazenil and glucose PET in children with extratemporal lobe epilepsy , 2000, Neurology.

[17]  M Vapalahti,et al.  [11 C]Flumazenil binding in the medial temporal lobe in patients with temporal lobe epilepsy: correlation with hippocampal MR volumetry, T2 relaxometry, and neuropathology. , 2000, Neurology.

[18]  Bengt Långström,et al.  NMDA‐Receptor Activity Visualized with (S)‐[N‐Methyl‐11C]Ketamine and Positron Emission Tomography in Patients with Medial Temporal Lobe Epilepsy , 1999, Epilepsia.

[19]  S. Sato,et al.  Postoperative changes in cerebral metabolism in temporal lobe epilepsy. , 2000, Archives of neurology.

[20]  O Muzik,et al.  Electroclinical correlates of flumazenil and fluorodeoxyglucose PET abnormalities in lesional epilepsy , 2000, Neurology.

[21]  O Muzik,et al.  Imaging epileptogenic tubers in children with tuberous sclerosis complex usingα‐[11C]Methyl‐L‐tryptophan positron emission tomography , 1998, Annals of neurology.

[22]  O Muzik,et al.  Sturge–Weber syndrome , 2001, Neurology.

[23]  J C Mazziotta,et al.  Interictal cerebral glucose metabolism in partial epilepsy and its relation to EEG changes , 1982, Annals of neurology.

[24]  O W Witte,et al.  Metabolic and electrophysiological alterations in an animal model of neocortical neuronal migration disorder , 2001, Neuroreport.

[25]  Juan Bulacio,et al.  Seizure outcome after epilepsy surgery in children and adolescents , 1998, Annals of neurology.

[26]  D W Roberts,et al.  Medically Intractable, Localization‐related Epilepsy with Normal MRI: Presurgical Evaluation and Surgical Outcome in 43 Patients , 2001, Epilepsia.

[27]  O. Muzik,et al.  Relationship between EEG and positron emission tomography abnormalities in clinical epilepsy. , 2000, Journal of clinical neurophysiology : official publication of the American Electroencephalographic Society.

[28]  O. Muzik,et al.  Glucose and [11C]flumazenil positron emission tomography abnormalities of thalamic nuclei in temporal lobe epilepsy , 1999, Neurology.

[29]  H. Chugani,et al.  Patterns of Cerebral Glucose Metabolism in Early and Late Stages of Rasmussen's Syndrome , 2001, Journal of child neurology.

[30]  D. Lee,et al.  Diagnostic Performance of [18F]FDG‐PET and Ictal [99mTc]‐HMPAO SPECT in Occipital Lobe Epilepsy , 2001, Epilepsia.

[31]  Otto Muzik,et al.  Is epileptogenic cortex truly hypometabolic on interictal positron emission tomography? , 2000, Annals of neurology.

[32]  S. Sato,et al.  FDG-PET and volumetric MRI in the evaluation of patients with partial epilepsy , 1995, Neurology.

[33]  A. Alavi,et al.  Ipsilateral and contralateral thalamic hypometabolism as a predictor of outcome after temporal lobectomy for seizures. , 2000, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[34]  Edouard Hirsch,et al.  Correlation between PET and SISCOM in temporal lobe epilepsy. , 2002, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[35]  M. Sasaki,et al.  Carbon-11-methionine PET in focal cortical dysplasia: a comparison with fluorine-18-FDG PET and technetium-99m-ECD SPECT. , 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[36]  C. Binnie,et al.  Significance of interictal bilateral temporal hypometabolism in temporal lobe epilepsy , 2000, Neurology.

[37]  Conrad V. Kufta,et al.  FDG‐Positron Emission Tomography and Invasive EEG: Seizure Focus Detection and Surgical Outcome , 1997, Epilepsia.

[38]  S. Trottier,et al.  The serotonergic innervation of the cerebral cortex in man and its changes in focal cortical dysplasia , 1996, Epilepsy Research.

[39]  K. Meador,et al.  Pathophysiology of altered consciousness during seizures: Subtraction SPECT study , 2002, Neurology.

[40]  D J Brooks,et al.  Ketone bodies do not directly alter excitatory or inhibitory hippocampal synaptic transmission , 2000, Neurology.

[41]  K. Dunigan,et al.  Cortical dysplasia localized by [11C]methionine positron emission tomography: case report. , 2002, AJNR. American journal of neuroradiology.

[42]  R. Kuzniecky,et al.  Relative utility of 1H spectroscopic imaging and hippocampal volumetry in the lateralization of mesial temporal lobe epilepsy , 1998, Neurology.

[43]  O Muzik,et al.  Relationship of flumazenil and glucose PET abnormalities to neocortical epilepsy surgery outcome , 2001, Neurology.

[44]  A. Wyler,et al.  Levels of biogenic amines, their metabolites, and tyrosine hydroxylase activity in the human epileptic temporal cortex , 1990, Synapse.

[45]  J. Mazziotta,et al.  Interictal metabolic anatomy of mesial temporal lobe epilepsy. , 1993, Archives of neurology.

[46]  J C Mazziotta,et al.  The lennox‐gastaut syndrome: Metabolic subtypes determined by 2‐deoxy‐2 [18F]fluoro‐d‐glucose positron emission tomography , 1987, Annals of neurology.

[47]  P. Crino,et al.  Cellular and molecular basis of cerebral dysgenesis , 1997, Journal of neuroscience research.

[48]  M E Phelps,et al.  Hemimegalencephaly: evaluation with positron emission tomography. , 1993, Pediatric neurology.

[49]  M E Phelps,et al.  Patterns of human local cerebral glucose metabolism during epileptic seizures. , 1982, Science.

[50]  W C Eckelman,et al.  PET imaging of 5-HT1A receptor binding in patients with temporal lobe epilepsy , 2003, Neurology.

[51]  Kazuhiko Yanai,et al.  Histamine H1 receptors in complex partial seizures , 1993, The Lancet.

[52]  M. Behen,et al.  Bilateral Medial Prefrontal and Temporal Neocortical Hypometabolism in Children with Epilepsy and Aggression , 2001, Epilepsia.

[53]  J C Mazziotta,et al.  Sturge-Weber syndrome: a study of cerebral glucose utilization with positron emission tomography. , 1989, The Journal of pediatrics.

[54]  S. Larson,et al.  Cerebral glucose metabolism in the Lennox‐Gastaut syndrome , 1987, Annals of neurology.

[55]  M Diksic,et al.  Localizing value of α-methyl-L-tryptophan PET in intractable epilepsy of neocortical origin , 2001, Neurology.

[56]  M. Gutnick,et al.  Hyperexcitability in a model of cortical maldevelopment. , 1996, Cerebral cortex.

[57]  Otto Muzik,et al.  [11ClFlumazenil PET in Patients with Epilepsy with Dual Pathology , 1999, Epilepsia.

[58]  M Vapalahti,et al.  [18F]FDG-PET reveals temporal hypometabolism in patients with temporal lobe epilepsy even when quantitative MRI and histopathological analysis show only mild hippocampal damage. , 2001, Archives of neurology.

[59]  M. Mandelkern,et al.  Neuroimaging in Temporal Lobe Epilepsy: Test Sensitivity and Relationships to Pathology and Postoperative Outcome , 1992, Epilepsia.